Patent ID: 11879012
Assignee: PETER GILLIES
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 0:
1. A method for treating a condition associated with aberrant keratinocyte epithelial cell proliferation, the method comprising:
a) obtaining a sample of keratinocyte epithelial cells from a subject;
b) determining the level of P-selectin expression in the sample;
c) comparing the level of P-selectin expression to a reference value, wherein a level of P-selectin that is equal to or greater than the reference value is indicative of the presence of a condition associated with aberrant keratinocyte epithelial cell proliferation; and
d) treating a subject identified in step c) as having a condition associated with aberrant keratinocyte epithelial cell proliferation with an effective amount of an agent that inhibits P-selectin expression and/or activity.